Davita Healthcare Partners Inc
(DVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 760,307 | 542,767 | 287,895 | 1,021,294 | 718,332 |
| Depreciation Amortization | 468,949 | 312,055 | 154,679 | 615,152 | 456,685 |
| Income taxes - deferred | 191,783 | 132,101 | 103,301 | 41,723 | 72,590 |
| Accounts receivable | -12,405 | 15,194 | -32,966 | -79,957 | -182,684 |
| Accounts payable and accrued liabilities | 445 | -15,858 | -24,045 | -84,539 | -106,662 |
| Other Working Capital | -92,281 | -22,302 | -201,821 | 86,859 | -114,331 |
| Other Operating Activity | 177,432 | 47,546 | 73,338 | 471,823 | 547,895 |
| Operating Cash Flow | $1,494,230 | $1,011,503 | $360,381 | $2,072,355 | $1,391,825 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 558 | -134,458 | -4,414 | 93,594 | -97,589 |
| PPE Investments | -366,557 | -221,052 | -123,424 | 3,110,846 | 3,316,436 |
| Net Acquisitions | -112,597 | -44,267 | -34,107 | -100,861 | -77,348 |
| Purchase Of Investment | -9,613 | -8,101 | -1,125 | -110,828 | -8,770 |
| Other Investing Activity | 902 | 739 | 445 | 2,589 | 1,296 |
| Investing Cash Flow | $-487,307 | $-407,139 | $-162,625 | $2,995,340 | $3,134,025 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,826,484 | 2,324,300 | 570,779 | 38,525,850 | 38,519,990 |
| Debt Repayment | -3,927,411 | -635,695 | -104,592 | -40,520,720 | -40,485,410 |
| Common Stock Issued | 3,838 | -2,106 | 2,397 | 11,382 | 7,333 |
| Common Stock Repurchased | -1,025,878 | -321,798 | -321,798 | -2,383,816 | -1,837,022 |
| Other Financing Activity | -258,731 | -125,128 | -49,794 | -329,146 | -208,655 |
| Financing Cash Flow | $-1,381,698 | $1,239,573 | $96,992 | $-4,696,450 | $-4,003,764 |
| Exchange Rate Effect | -16,606 | -16,936 | -14,978 | -1,760 | -4,178 |
| Beginning Cash Position | 1,208,718 | 1,208,718 | 1,208,718 | 415,420 | 415,420 |
| End Cash Position | 817,337 | 3,035,719 | 1,488,488 | 1,208,718 | 1,357,141 |
| Net Cash Flow | $-391,381 | $1,827,001 | $279,770 | $793,298 | $941,721 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,494,230 | 1,011,503 | 360,381 | 2,072,355 | 1,391,825 |
| Capital Expenditure | -449,896 | -291,667 | -154,942 | -766,546 | -547,183 |
| Free Cash Flow | 1,044,334 | 719,836 | 205,439 | 1,305,809 | 844,642 |